Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Introduction to Epidemiology01:26

Introduction to Epidemiology

1.2K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.2K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

522
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
522
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

635
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
635
Pharmacovigilance01:19

Pharmacovigilance

1.2K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
Observational Studies01:11

Observational Studies

10.2K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constructing Genetic Risk Scores: Robust Bayesian Approach through Projected Summary Statistics and Flexible Shrinkage.

Journal of the American Statistical Association·2026
Same author

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study.

Ophthalmology·2026
Same author

Prone Positioning in a North American Cohort of Hypoxemic Patients on Mechanical Ventilation.

Critical care medicine·2026
Same author

Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus.

Journal of the American College of Cardiology·2026
Same author

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes.

Nature communications·2026
Same author

NeMO Analytics: a compendium of transcriptomic data for the exploration of neocortical development.

Nature neuroscience·2026

Related Experiment Video

Updated: Oct 24, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

813

Ten Rules for Conducting Retrospective Pharmacoepidemiological Analyses: Example COVID-19 Study.

Michael Powell1, Allison Koenecke2, James Brian Byrd3

  • 1Department of Biomedical Engineering, Institute for Computational Medicine, The Johns Hopkins University, Baltimore, MD, United States.

Frontiers in Pharmacology
|August 16, 2021
PubMed
Summary

This study outlines 10 rules for retrospective pharmacoepidemiological analysis of observational health data. These methods help evaluate pharmaceutical treatments for conditions like COVID-19, guiding future randomized controlled trials.

Keywords:
COVID-19drug repurposingobservational studypharmacoepidemiologyretrospective analyses

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Oct 24, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

813
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Pharmacoepidemiology
  • Health Data Analysis
  • Causal Inference

Background:

  • Evaluating pharmaceutical treatments requires robust evidence, often necessitating randomized controlled trials (RCTs).
  • Observational studies can provide preliminary evidence but face challenges due to non-randomized exposure and data collection limitations.
  • The COVID-19 pandemic highlighted the need for efficient evaluation of treatment hypotheses.

Purpose of the Study:

  • To introduce a framework of 10 rules for conducting retrospective pharmacoepidemiological analyses of observational health care data.
  • To guide researchers in assessing treatment hypotheses and informing the design of subsequent randomized controlled trials.
  • To provide a practical approach for leveraging observational data in drug development and evaluation, especially during public health crises.

Main Methods:

  • Development of a 10-rule framework for end-to-end retrospective pharmacoepidemiological analysis.
  • Utilizing a hypothetical COVID-19 treatment study as a running example.
  • Integration of expertise from epidemiology, causal analysis, medical specialties, and data sources.

Main Results:

  • The proposed 10 rules provide a structured approach to analyzing observational health care data.
  • A detailed supplement offers a practical guide for implementing each rule.
  • Properly executed analyses can effectively inform decisions regarding the initiation and design of randomized controlled trials.

Conclusions:

  • Retrospective pharmacoepidemiological analysis, guided by these rules, is crucial for evidence-based treatment evaluation.
  • This framework enhances the efficiency and credibility of investigating pharmaceutical treatments.
  • The methodology has significant implications for future pandemic preparedness and response strategies.